November 3, 2021
The new global Rare Disease center of Emmes expects accelerating growth from US and European biotechs. Emmes – a full service, global clinical research organization (CRO) […]
November 16, 2021
Emmes and MedGenome Launch Genomics Strategic Partnership Focused on Advancing Rare Disease Research
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced a partnership with MedGenome aimed […]